N. Pescalli

发表

tumor-selective pharmacologic profile competitive with bortezomib CEP-18770: A novel, orally active proteasome inhibitor with a

H. Ovaa, G. Inghirami, A. Neri, 2008 .

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.

H. Ovaa, G. Inghirami, A. Neri, 2008, Blood.

1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.

L. Kèlland, S. Martelli, B. Stefańska, 1997, Journal of medicinal chemistry.

2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: synthesis, biological evaluation, and structure-activity relationships.

L. Kèlland, S. Martelli, I. Antonini, 1999, Journal of medicinal chemistry.

2,6-Di(omega-aminoalkyl)-2,5,6,7-tetrahydropyrazolo[3,4,5-mn]pyrimido[5,6,1-de]acridine-5,7-diones: novel, potent, cytotoxic, and DNA-binding agents.

B. Gatto, M. Palumbo, S. Martelli, 2002, Journal of medicinal chemistry.

Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.

B. Gatto, M. Palumbo, S. Martelli, 2003, Journal of medicinal chemistry.

Pyrimido [4,5,6-kl] acridines, a new class of potential anticancer agents. Synthesis and biological evaluation.

S. Martelli, M. Bontemps-Gracz, I. Antonini, 1996, Anti-cancer drug design.

Effects of naftopidil on some urodynamic parameters and arterial blood pressure in comparison with prazosin in conscious rats.

G. Sponer, N. Pescalli, R. Ceserani, 1996, Pharmacological research.

N4-(ω-Aminoalkyl)-1-[(ω-aminoalkyl)amino]-4-acridinecarboxamides: Novel, Potent, Cytotoxic, and DNA-Binding Agents

L. Kèlland, S. Martelli, I. Antonini, 2000 .

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.

H. Ovaa, G. Inghirami, A. Neri, 2008, Blood.

Cytotoxicity evaluation of natural coptisine and synthesis of coptisine from berberine.

N. Pescalli, E. Menta, L. Piazzoni, 2001, Farmaco.